Booster Dose of sIPV Co-administered With MMR and HepA-I.
Clinical trial NCT06442449 · COMPLETED
Trial details
- NCT number
- NCT06442449
- Sponsor
- Sinovac Biotech Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-08
- Primary completion
- 2025-09-10
- Enrollment
- 889
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.